Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Dec 22;10(1):2.
doi: 10.3390/ijns10010002.

Incidental Detection of Classical Galactosemia through Newborn Screening for Phenylketonuria: A 10-Year Retrospective Audit to Determine the Efficacy of This Approach

Affiliations

Incidental Detection of Classical Galactosemia through Newborn Screening for Phenylketonuria: A 10-Year Retrospective Audit to Determine the Efficacy of This Approach

Nathan W P Cantley et al. Int J Neonatal Screen. .

Abstract

In the UK, Classical Galactosaemia (CG) is identified incidentally from the Newborn Screening (NBS) for phenylketonuria (PKU) using an "Other disorder suspected" (ODS) pathway when phenylalanine (Phe) and tyrosine (Tyr) concentrations are increased. We aimed to determine the efficacy of CG detection via NBS and estimate the incidence of CG in live births in the UK. A survey was sent to all UK NBS laboratories to collate CG cases diagnosed in the UK from 2010 to 2020. Cases of CG diagnosed were determined if detected clinically, NBS, or by family screening, as well as age at diagnosis. Cases referred via the ODS pathway were also collated, including the final diagnosis made. Responses were obtained from 13/16 laboratories. Between 2010 and 2020, a total of 6,642,787 babies were screened, and 172 cases of CG were identified. It should be noted that 85/172 presented clinically, 52/172 were identified by NBS, and 17/172 came from family screening. A total of 117 referrals were made via the ODS pathway, and 45/117 were subsequently diagnosed with CG. Median (interquartile range) age at diagnosis by NBS and clinically was 8 days (7-11) and 10 days (7-16), respectively (Mann-Whitney U test, U = 836.5, p-value = 0.082). The incidence of CG is 1:38,621 live births. The incidence of CG in the UK is comparable with that of other European/western countries. No statistical difference was seen in the timing of diagnosis between NBS and clinical presentation based on the current practice of sampling on day 5. Bringing forward the day of NBS sampling to day 3 would increase the proportion diagnosed with CG by NBS from 52/172 (30.2%) to 66/172 (38.4%).

Keywords: classical galactosaemia; newborn screening; phenylalanine; phenylketonuria; tyrosine.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
Current UK NBS protocol for the detection of suspected cases of Phenylketonuria (PKU) [9]. Figure contains public sector information licensed under the Open Government Licence v2.0.

References

    1. Downing M., Pollitt R. Newborn bloodspot screening in the UK—Past, present and future. Pt 1Ann. Clin. Biochem. 2008;45:11–17. doi: 10.1258/acb.2007.007127. - DOI - PubMed
    1. Pollitt R.J., Worthy E., Green A. Galactosaemia detection as a bonus from screening for phenylketonuria. J. Inherit. Metab. Dis. 1982;5((Suppl. 1)):51–52. doi: 10.1007/BF01799824. - DOI
    1. Shakespeare L., Downing M., Allen J., Casbolt A.-M., Ellin S., Maloney M., Race G., Bonham J. Elevated phenylalanine on newborn screening: Follow-up testing may reveal undiagnosed galactosaemia. Pt 6Ann. Clin. Biochem. 2010;47:567–569. doi: 10.1258/acb.2010.010083. - DOI - PubMed
    1. Kotb M.A., Mansour L., Shamma R.A. Screening for galactosemia: Is there a place for it? Int. J. Gen. Med. 2019;12:193–205. doi: 10.2147/IJGM.S180706. - DOI - PMC - PubMed
    1. Pyhtila B.M., Shaw K.A., Neumann S.E., Fridovich-Keil J.L. Newborn screening for galactosemia in the United States: Looking back, looking around, and looking ahead. JIMD Rep. 2015;15:79–93. doi: 10.1007/8904_2014_302. Erratum in JIMD Rep. 2015, 15, 133. - DOI - PMC - PubMed